Breast and ovarian cancer risks in a large series of clinically ascertained families with a high proportion of BRCA1 and BRCA2 Dutch founder mutations

R.M. Brohet, M.E. Velthuizen, F.B.L. Hogervorst, H.E.J. Meijers-Heijboer, C. Seynaeve, M.J. Collee, S Verhoef, M.G.E.M. Ausems, N. Hoogerbrugge, C.J. van Asperen, E.G. Garcia, F. Menko, J.C. Oosterwijk, P. Devilee, L.J. van 't Veer, F.E. van Leeuwen, D.F. Easton, M.A. Rookus, A.C. Antoniou

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)98-107
JournalJournal of Medical Genetics
Volume51
Issue number2
DOIs
Publication statusPublished - 2014

Cite this

Brohet, R. M., Velthuizen, M. E., Hogervorst, F. B. L., Meijers-Heijboer, H. E. J., Seynaeve, C., Collee, M. J., Verhoef, S., Ausems, M. G. E. M., Hoogerbrugge, N., van Asperen, C. J., Garcia, E. G., Menko, F., Oosterwijk, J. C., Devilee, P., van 't Veer, L. J., van Leeuwen, F. E., Easton, D. F., Rookus, M. A., & Antoniou, A. C. (2014). Breast and ovarian cancer risks in a large series of clinically ascertained families with a high proportion of BRCA1 and BRCA2 Dutch founder mutations. Journal of Medical Genetics, 51(2), 98-107. https://doi.org/10.1136/jmedgenet-2013-101974